Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial

Study Questions:

Does olmesartan, an angiotensin-receptor blocker (ARB), prevent paroxysmal atrial fibrillation (AF)?